Division of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):839-43. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.018. Epub 2011 Jun 2.
Many patients with stroke-mimicking conditions receive treatment with intravenous fibrinolysis (IVF), a treatment associated with potentially serious complications. We sought to determine if any clinical or radiographic characteristics can help predict stroke mimics among IVF candidates.
This retrospective study was carried out at a single institution. Patients treated with intravenous recombinant tissue plasminogen activator (rt-PA; n = 193) were divided into 3 categories: acute ischemic stroke (n = 142), aborted stroke (n = 21), and stroke mimics (n = 30). Analysis of variance and the chi-square test were used to assess differences, while logistic regression models were computed to predict groups.
Mimics treated with rt-PA did not experience complications (intracranial bleeding, systemic hemorrhage, or angioedema), and had better neurologic and functional outcomes than stroke patients (P < .05). Several variables helped differentiate strokes from mimics, including atherosclerosis on computed tomographic angiography (odds ratio [OR] 23.6; 95% confidence interval [CI] 8.4-66.2), atrial fibrillation (OR 11.4; 95% CI 1.5-86.3), age >50 years (OR 7.2; 95% CI 2.8-18.5), and focal weakness (OR 4.15; 95% CI 1.75-9.8). Other variables decreased chances of stroke: migraine history (OR 0.05; 95% CI 0.01-0.4), epilepsy (OR 0.13; 95% CI 0.02-0.8), paresthesia (OR 0.1; 95% CI 0.04-0.3), and precordialgia (OR 0.045; 95% CI 0.002-0.9). A regression model using focal weakness, computed tomographic angiography findings, and precordialgia had a 90.2% predictive accuracy.
IVF has low complication rates in stroke mimics. Certain clinical characteristics appear predictive of stroke mimics, particularly normal computed tomographic angiography. If confirmed, this may help prevent giving IVF to patients without stroke.
许多患有类似中风的病症的患者接受静脉溶栓治疗(IVF),这种治疗方法可能会导致严重的并发症。我们试图确定是否存在任何临床或影像学特征可以帮助预测 IVF 患者中的中风模拟。
本回顾性研究在一家医疗机构进行。接受静脉重组组织型纤溶酶原激活剂(rt-PA;n = 193)治疗的患者分为 3 类:急性缺血性中风(n = 142)、中风发作(n = 21)和中风模拟(n = 30)。方差分析和卡方检验用于评估差异,而逻辑回归模型用于预测组。
接受 rt-PA 治疗的模拟中风患者没有出现并发症(颅内出血、全身出血或血管性水肿),并且神经功能和功能结果优于中风患者(P <.05)。一些变量有助于区分中风和模拟中风,包括 CT 血管造影上的动脉粥样硬化(优势比[OR] 23.6;95%置信区间[CI] 8.4-66.2)、心房颤动(OR 11.4;95% CI 1.5-86.3)、年龄 >50 岁(OR 7.2;95% CI 2.8-18.5)和局灶性无力(OR 4.15;95% CI 1.75-9.8)。其他变量降低了中风的可能性:偏头痛病史(OR 0.05;95% CI 0.01-0.4)、癫痫(OR 0.13;95% CI 0.02-0.8)、感觉异常(OR 0.1;95% CI 0.04-0.3)和胸痛(OR 0.045;95% CI 0.002-0.9)。使用局灶性无力、CT 血管造影发现和胸痛的回归模型具有 90.2%的预测准确性。
IVF 在中风模拟中具有较低的并发症发生率。某些临床特征似乎可以预测中风模拟,特别是正常的 CT 血管造影。如果得到证实,这可能有助于防止给没有中风的患者使用 IVF。